HCHenry Claireaux

Henry Claireaux

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Henry Claireaux has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioactive Glass Dressings for Infected Wounds: A Systematic Review

    by Nandesh C. Patel, Thomas J. Howe, Henry A. Claireaux, Julian R. Jones, Arul Ramasamy

    Wounds pose a clinical challenge due to their susceptibility to infection and complex healing environments. Wound infection with multi‐drug‐resistant bacteria increases the mortality and morbidity, with new strategies needed to treat them. Bioactive glasses are biodegradable glasses that interact with biological systems by releasing ions such as Na + , Ca 2+ and borate. They are emerging as promising adjuncts in managing infected wounds. This review aims to synthesise the current evidence on the role of bioactive glass in infected wounds. This systematic review was reported as per PRISMA 2020 and PRISMA‐S. Medline, EMBASE and CINAHL Complete were searched using a research librarian designed strategy. In vivo studies were screened in duplicate by two blinded authors and quality was assessed with no limitation on study type. Heterogeneity precluded meta‐analysis. Twenty in vivo animal studies were included. Most studies investigated mesoporous or dense nanoparticles ( n = 17) in murine models ( n = 20) infected with S. aureus . Overall, bioactive glass preparations had faster wound healing compared to comparators by day 14. They consistently reduced bacterial burden in infected animal wound models, with faster and more complete remodelling resulting in better structural and functional skin regeneration. Despite promising results, certainty of evidence was low. This systematic review demonstrates the promise of bioactive glass wound dressings for infected wounds. Findings complement those showing benefit in diabetic chronic wound healing in addition to bone and joint infection. Further research is required to compare bioactive glass dressings to standard‐of‐care dressings to pave the way for first‐in‐human trials to translate these biomaterials for clinical use.

  • Open Access

    Antimicrobial-laden PerOssal beads display in vitro inhibition and killing of extensively drug-resistant Gram-negative bacteria associated with conflict wounds in Ukraine

    by Henry Adam Claireaux, Edward J. A. Douglas, Scott J. C. Pallett, Luke S. P. Moore, Matthew K. O'SHea, Olena V. Moshynets, Julian R. Jones, Arul Ramasamy, Andrew M. Edwards

    Aims: Open fractures sustained in contemporary conflict are associated with high-energy transfer, contamination with resistant bacteria, and delays to surgical care, resulting in high rates of infection. Similar conditions occur in civilian disasters, where crush injuries and overwhelmed healthcare systems prolong the interval to surgical wound excision. Prophylactic systemic antimicrobial regimens may be ineffective due to antimicrobial resistance or limited bioavailability in bone and joint tissues. Local antimicrobial delivery can provide higher drug concentrations within the wound, which may be sufficient to overcome resistance. This route is established in bone and joint infection, although evidence in conflict trauma is lacking. We evaluated the in vitro activity of antimicrobial-laden PerOssal hydroxyapatite and calcium sulphate beads. Methods: Bacterial isolates from Ukraine isolated from contaminated traumatic wounds were tested, including extensively drug-resistant (XDR) Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and Escherichia coli . The antimicrobial effects of antimicrobial-laden PerOssal beads were assessed by zone-of-inhibition testing and time-kill analysis. Results: All Gram-negative isolates from Ukraine were resistant to gentamicin, tobramycin, co-amoxiclav, cefazolin, and ciprofloxacin, with minimum inhibitory concentrations (MICs) exceeding European Committee on Animicrobial Susceptibility Testing (EUCAST) breakpoints. PerOssal beads laden with gentamicin, tobramycin, or cefazolin were weakly growth inhibitory. However, gentamicin–rifampicin in combination achieved consistent broad-spectrum bacterial inhibition and killing, while co-amoxiclav-loaded beads inhibited the growth of all bacterial strains. Conclusion: Antimicrobial-laden PerOssal hydroxyapatite and calcium sulphate beads displayed in vitro inhibition and killing of XDR Gram-negative bacteria associated with contaminated traumatic wounds. Early local antimicrobial delivery may reduce infection risk following heavily contaminated open fractures, particularly when surgical wound excision is delayed. This may be relevant to both modern conflict and civilian disaster settings. Further work is required to determine the effectiveness of this approach in vivo. Cite this article: Bone Joint Res 2026;15(8):1055–1066.

  • Open Access

    Conflict wounds and antimicrobial resistance: a systematic review on local antimicrobials to prevent infection after extremity open fracture

    by Henry A Claireaux, Scott Jc Pallett, Luke Sp Moore, Andrew M Edwards, Julian R Jones, Matthew K O’SHea, Arul Ramasamy

    Introduction: Contemporary conflict-associated injuries with open fractures are challenged by infection and antimicrobial resistance (AMR), compromising empiric antimicrobials and limiting options for systemic treatment. Local antimicrobials in high concentrations may offer an adjunctive therapy but the evidence and its relevance to conflict settings are unclear. Methods: A systematic review was undertaken using the Medline, Embase and Cochrane databases, searching for evidence relating to the use of local antimicrobials to prevent infection after extremity open fracture. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. The review considered evidence for the effect of local antimicrobials across different agents, different causes of infection, AMR and adverse effects. Available evidence was considered in the context of its relevance to conflict injuries and priority research gaps were identified. Results: No studies were identified in conflict or humanitarian settings. Seven civilian systematic reviews and meta-analyses considering different outcomes and four randomised controlled trials (RCTs) were identified. There was low-quality evidence for a reduction in infection when using prophylactic local antimicrobials in addition to systemic antimicrobials, and there was no evidence of adverse outcomes. Evidence skewed towards use for Gram-positive infections. There was a lack of level one evidence and marked heterogeneity across study designs. Conclusion: AMR has emerged as a major challenge for the management of open fractures sustained in conflict. There is an urgent requirement to identify alternative treatment options and adjuncts. Local antimicrobials and biomaterials present potential opportunities. Further evidence from RCTs is required across all settings. In the context of conflict, this must include relevant outcomes, including the impact of delayed surgery, wound contamination and AMR.


  • Open Access

    Assessment of proprietary and improvised pelvic binders: time to application and displacement during casualty evacuation

    by Thomas John Howe, H Claireaux, G Morgan, L McMenemy, S D Masouros, A Ramasamy

    Introduction: Pelvic injuries resulting from high-energy trauma have an approximately 10% mortality rate. Suspected pelvic injuries are treated with pelvic binders to stabilise fractured bones and promote tamponade until surgical treatment. The effectiveness of pelvic binders in reducing mortality risk depends on accurate positioning of the binder. This study quantifies the ability of proprietary and improvised pelvic binders to maintain their positioning during a simulated casualty evacuation. Methods: One improvised and three proprietary pelvic binders were tested in their ability to maintain their initial placement. Combat Medical Technicians applied binders to healthy subjects and then performed a simulated casualty evacuation. The time taken to apply each binder was measured. The evacuation consisted of: 20 m casualty drag, transfer onto a soft stretcher, 100 m evacuation on a soft stretcher, transfer onto a rigid stretcher and transfer into a field ambulance. Binder placement was measured using bony landmarks after the initial positioning and after each phase of the simulated casualty evacuation. Results: The field-expedient pelvic splint (FEPS), SAM Pelvic Sling II (SAM) and T-POD Pelvic Stabilisation Device (TPOD) all remained within 45 mm of vertical displacement from their initial placement, which is considered an acceptable range for optimal binder functionality. The Prometheus Pelvic Splint (PROM) fell within this range in 83% of trials. The SAM was the fastest binder to apply, followed by the TPOD, and then the FEPS and PROM which took similar times to apply. Conclusions: Binders were mostly able to maintain their positioning during the simulated casualty evacuations carried out in this study but differed in their application times. The improvised binder (FEPS) performed comparably to the proprietary binders tested, and its low cost and weight make it a good alternative to proprietary binders in the austere environment.


  • Open Access

    Mechanical assessment of proprietary and improvised pelvic binders for use in the prehospital environment

    by Thomas John Howe, H Claireaux, H Fox, G Morgan, L McMenemy, S D Masouros, A Ramasamy

    Introduction Pelvic fractures often result from high-energy trauma and are associated with a 10% mortality rate and significant morbidity. Pelvic binders are applied in suspected pelvic injury to stabilise fractured bone, decrease bleeding and potentiate tamponade. A binder must hold the pelvis with sufficient force for this effect to be achieved. This study aims to quantify the ability of proprietary and improvised pelvic binders to hold a target tensile force over time. Methods The ability of three proprietary and three improvised binders to hold a binding force for 2 hours was tested. A uniaxial materials testing machine was used to tension each binder to 150 N and then hold the displacement for 2 hours; the drop in tension over time was recorded for each binder. The ability to hold tension above 130 N after 2 hours was set as the metric of binder performance. Results The median tension at 2 hours was above 130 N for the SAM Pelvic Sling II and T-POD Pelvic Stabilisation Device and was below 130 N for the Prometheus Pelvic Splint, field-expedient pelvic splint (FES) and the Personal Clothing System-Multi-Terrain Pattern Combat Trousers binders. The tension in the improvised FES after 2 hours was approximately at the target 130 N; however, in 40% of the tests, it held above 130 N. Conclusions Binders varied in their ability to maintain sufficient tension to treat a pelvic fracture over the 2-hour testing period. The FES performed well under our testing regime; with relatively low cost and weight, it represents a good alternative to proprietary binders for the austere environment.


  • Open Access

    What outcomes have been reported on patients following open lower limb fracture, and how have they been measured?

    by Alexander L. Aquilina, Henry Claireaux, Christian O. Aquilina, Elizabeth Tutton, Raymond Fitzpatrick, Matthew L. Costa, Xavier L. Griffin

    What outcomes have been reported on patients following open lower limb fracture, and how have they been measured?


  • Free functional muscle transfer for upper limb paralysis – A systematic review

    by Alistair Jm Reed, Henry A Claireaux, Justin Cr Wormald, Neal Thurley, Rebecca Shirley, James Kk Chan


  • Open Access

    Peri‐operative administration of tranexamic acid in lower limb arthroplasty: a multicentre, prospective cohort study

    by T. D. Lloyd, G. Neal‐Smith, J. Fennelly, H. Claireaux, C. Bretherton, A. J. Carr, M. Murphy, B. J. Kendrick, A. J. R. Palmer, Collaborators

    Summary: In the UK , tranexamic acid is recommended for all surgical procedures where expected blood loss exceeds 500 ml. However, the optimal dose, route and timing of administration are not known. This study aimed to evaluate current practice of peri‐operative tranexamic acid administration. Patients undergoing primary total hip arthroplasty, total knee arthroplasty or unicompartmental knee arthroplasty during a 2‐week period were eligible for inclusion in this prospective study. The primary outcome was the proportion of patients receiving tranexamic acid in the peri‐operative period. Secondary outcomes included: dose, route and timing of tranexamic acid administration; prevalence of pre‐ and postoperative anaemia; estimated blood loss; and red blood cell transfusion rates. In total, we recruited 1701 patients from 56 NHS hospitals. Out of these, 1523 (89.5%) patients received tranexamic acid and of those, 1052 (69.1%) received a single dose of 1000 mg intravenously either pre‐ or intra‐operatively. Out of the 1701 patients, 571 (33.6%) and 1386 (81.5%) patients were anaemic (haemoglobin < 130 g.l −1 ) in the pre‐ and postoperative period, respectively. Mean ( SD ) estimated blood loss for all included patients was 792 (453) ml and 54 patients (3.1%) received a red blood cell transfusion postoperatively. The transfusion rate for patients with pre‐operative anaemia was 6.5%, compared with 1.5% in patients without anaemia. Current standard of care in the UK is to administer 1000 mg of tranexamic intravenously either pre‐ or intra‐operatively. Approximately one‐third of patients present for surgery with anaemia, although the overall red blood cell transfusion rate is low. These data provide useful comparators when assessing the efficacy of tranexamic acid and other patient blood management interventions in future studies.


  • Open Access

    Multicentre collaborative cohort study of the use of Kirschner wires for the management of supracondylar fractures in children

    by Henry Claireaux, Richard Goodall, Joshua Hill, Elizabeth Wilson, Philippa Coull, Sebastian Green, James Schuster-Bruce, Diana Lim, Joanna Miles, Payam Tarassoli